With Revenues Climbing and Journals Publishing, Ciphergen Picks up Steam | GenomeWeb

There seems to be only good news from Ciphergen these days. Not only has the Fremont, Calif., protein science company been racking up increased revenues and rolling out new products, a recent publication in a top medical journal has added the stamp of scientific validation to the company’s technology, and two prestigious AIDS research institutes have signed on to use it for protein profiling.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.